Trial Profile
New Influenza A (H1N1) disease incidence and immunogenicity of the pandemic influenza A (H1N1) vaccine in healthy adults.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- Sponsors Netherlands Vaccine Institute
- 06 Apr 2022 This trial has been completed in Netherland (Global end date: 12/04/2011), according to European Clinical Trials Database record.
- 07 Nov 2009 New trial record